| For: | He Y, Liu J, Zhou N, Xie LX, Jiang YF, Chen CL. Peroxiredoxin 1 inhibits tumorigenesis by activating the NLRP3/GSDMD pathway to induce pyroptosis of colorectal cancer cells. World J Gastroenterol 2025; 31(36): 111557 [PMID: 41025079 DOI: 10.3748/wjg.v31.i36.111557] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v31/i36/111557.htm |
| Number | Citing Articles |
| 1 |
Ilaria Pagliassotto, Pier Paolo Bocchino, Lucia Elena Laiso, Riccardo Pilia, Maria Luisa Carbone, Simone Frea, Guglielmo Gallone, Filippo Angelini, Gaetano Maria De Ferrari. Current landscape for outcome prediction in patients with cardiogenic shock. Future Cardiology 2026; 22(4) doi: 10.1080/14796678.2026.2664540
|
| 2 |
Zi-Ke Chen, Jia-Wei Zhao, Wen-Ying Meng, Yu-Gang Wang. Peroxiredoxin 1 as a novel pyroptosis inducer in colorectal cancer: Insights and future directions. World Journal of Gastroenterology 2026; 32(8): 116016 doi: 10.3748/wjg.v32.i8.116016
|
| 3 |
Dharmendra Kumar Maurya. Peroxiredoxin 1, pyroptosis, and the emerging frontier in colorectal cancer therapy. World Journal of Gastroenterology 2026; 32(1): 114184 doi: 10.3748/wjg.v32.i1.114184
|
| 4 |
Anna Smirnova, Daria Eygel, Irina Kondrasheva, Denis S Baranovskii, Ilya D Klabukov. Peroxiredoxin 1 inhibits tumorigenesis by activating the NLR family pyrin domain containing 3/gasdermin D pathway: Advanced therapies targeting heterogeneous cell death mechanisms. World Journal of Gastroenterology 2025; 31(44): 114404 doi: 10.3748/wjg.v31.i44.114404
|
| 5 |
Yosup Kim, Eun-Kyung Kim, Ho Hee Jang. Moonlighting Functions of Mammalian Peroxiredoxins in Cellular Signaling. Antioxidants 2026; 15(2) doi: 10.3390/antiox15020231
|